Promising of Multidrug-resistant Tuberculosis Screening among New Tuberculosis Patients in China

[1] reported that the MDR-TB burden among the new tuberculosis (TB) patients accounted for more than 1/4th of all multidrug-resistant TB (MDR-TB) cases in the past 5 years in Zhejiang province, although the identified rate of MDR-TB among 9830 new TB cases was only 2.0%. The "13th Five-Year Pla...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2017-09, Vol.130 (17), p.2142-2142
Main Authors: Zhang, Hui, Jia, Zhong-Wei
Format: Article
Language:English
Subjects:
Analysis
Antitubercular Agents
China
Comments
Diagnosis
Drug resistance
Drug Resistance, Multiple, Bacterial - drug effects
Health screening
Humans
Microbial drug resistance
Microbial Sensitivity Tests
Multidrug resistant organisms
Mycobacterium tuberculosis - drug effects
Tuberculosis
Tuberculosis, Multidrug-Resistant
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[1] reported that the MDR-TB burden among the new tuberculosis (TB) patients accounted for more than 1/4th of all multidrug-resistant TB (MDR-TB) cases in the past 5 years in Zhejiang province, although the identified rate of MDR-TB among 9830 new TB cases was only 2.0%. The "13th Five-Year Plan" of China NTP promised that all suspected pulmonary TB patients will be provided for sputum smear and culture examination and drug-resistance will be of course screened for etiologically positive pulmonary TB patients, including both new TB and those at high risk of MDR-TB.
ISSN:0366-6999
DOI:10.4103/0366-6999.213433